Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $6.0800 (-3.65%) ($6.0800 - $6.0800) on Thu. Aug. 24, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.95% (three month average) | RSI | 36 | Latest Price | $6.0800(-3.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.6% a day on average for past five trading days. | Weekly Trend | IOVA declines -7.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) SMH(56%) IPO(38%) SLV(36%) IGOV(35%) GDX(33%) | Factors Impacting IOVA price | IOVA will decline at least -2.475% in a week (0% probabilities). UUP(-39%) TAN(-36%) XME(-31%) XLU(-27%) TBT(-25%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.475% (StdDev 4.95%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-6.03(-199.18%) | Resistance Level | $6.89 | 5 Day Moving Average | $6.22(-2.25%) | 10 Day Moving Average | $6.58(-7.6%) | 20 Day Moving Average | $6.89(-11.76%) | To recent high | -31.4% | To recent low | 0.1% | Market Cap | $890m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |